{"schema_version":"1","generated_at":"2026-11-01T04:07:35.063Z","data_as_of":"2026-10-17","url":"https://www.findmykol.com/kol/susan-blaney","json_url":"https://www.findmykol.com/kol/susan-blaney/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"susan-blaney","name":"Susan Blaney","credential":"MD","title":"The Elise C. Young Chair in Pediatric Oncology, Director of Texas Children's Cancer and Hematology Centers, and Professor of Pediatrics at Baylor College of Medicine","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Leukemia","Sarcoma"],"institution":"Baylor College of Medicine","institution_url":"https://www.findmykol.com/institution/baylor-college-of-medicine","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1821178252","orcid":"0000-0002-6194-4799","openalex":"A5027468886"},"summary":"Susan Blaney is The Elise C. Young Chair in Pediatric Oncology, Director of Texas Children's Cancer and Hematology Centers, and Professor of Pediatrics at Baylor College of Medicine at Baylor College of Medicine. OpenAlex indexes 375 publications with 15,608 citations (h-index 75); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the FindMyKOL directory.","overview":{"text":"Susan Blaney, MD, is The Elise C. Young Chair in Pediatric Oncology, Director of Texas Children's Cancer and Hematology Centers, and Professor of Pediatrics at Baylor College of Medicine. The public record shows 375 publications with 15,608 citations (h-index 75), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Cancer therapeutics and mechanisms. It also documents an investigator role on 14 registered clinical trials, 6 NIH-funded awards (1997–2024).","bullets":["Most recent indexed publication: 2024 · Journal of clinical oncology","Top research focus: Glioma Diagnosis and Treatment","14 registered trials on ClinicalTrials.gov"],"generated_at":"2026-10-31"},"focus":{"indications":[{"label":"Central Nervous System Neoplasms","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Nervous System Neoplasms","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":2,"topics":1,"strength":7},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Meningitis","therapeutic_area":"Neurology","trials":2,"topics":0,"strength":6},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4},{"label":"HIV","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Myeloid, Acute","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Acquired Immunodeficiency Syndrome","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Hodgkin Disease","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"ST Elevation Myocardial Infarction","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Medulloblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Herpes Zoster","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Neuroblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Acute Lymphoblastic Leukemia research","Cancer therapeutics and mechanisms","Sarcoma Diagnosis and Treatment","Pharmaceutical studies and practices"],"works_with":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Baylor College of Medicine","trials":7,"payments":0,"mentions":7},{"name":"National Cancer Institute (NCI)","trials":3,"payments":0,"mentions":3},{"name":"Pediatric Brain Tumor Consortium","trials":3,"payments":0,"mentions":3}]}},"scholarship":{"works_count":375,"cited_by_count":15608,"h_index":75,"i10_index":204,"pubmed_count":1,"latest_activity_year":2024,"citation_standing":{"top_percent":10,"cohort":"Hematology / Oncology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":14,"shown":3,"withheld":11,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT00674674","title":"Phase 1 Intrathecal Topotecan for Neoplastic Meningitis","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Baylor College of Medicine","source_url":"https://clinicaltrials.gov/study/NCT00674674","trial_url":"https://www.findmykol.com/trial/NCT00674674"},{"nct":"NCT00586560","title":"Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Baylor College of Medicine","source_url":"https://clinicaltrials.gov/study/NCT00586560","trial_url":"https://www.findmykol.com/trial/NCT00586560"},{"nct":"NCT00503724","title":"Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors","phase":"PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Pediatric Brain Tumor Consortium","source_url":"https://clinicaltrials.gov/study/NCT00503724","trial_url":"https://www.findmykol.com/trial/NCT00503724"}],"source":"trials"},"payments":{"company_count":0,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1821178252","source":"payments"},"funding":{"award_count":6,"fiscal_years":{"first":1997,"last":2024},"rows_total":161,"shown":3,"withheld":158,"rows":[{"project":"P30CA125123","title":"Pediatric Cancer Program","fiscal_year":2024,"amount_usd":32567,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P30CA125123"},{"project":"K12CA090433","title":"PEDIATRIC ONCOLOGY CLINICAL RESEARCH TRAINING PROGRAM","fiscal_year":2023,"amount_usd":717393,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/K12CA090433"},{"project":"P30CA125123","title":"Pediatric Cancer Program","fiscal_year":2023,"amount_usd":32567,"organization":"BAYLOR COLLEGE OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/P30CA125123"}],"source":"grants"},"congress":{"count":59,"years":{"first":2004,"last":2017},"societies":["AACR","ASCO","ASTRO"],"shown":3,"withheld":56,"rows":[{"title":"Phase 2 trial of brentuximab vedotin and gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma (HL): A Children’s Oncology Group (COG) report.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2017,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.7527","source_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.7527","status":"verified"},{"title":"A phase 1 study of eribulin mesylate (E7389), a novel microtubule targeting chemotherapeutic agent in children with refractory or recurrent solid tumors (excluding CNS), including lymphomas: a Children's Oncology Group Phase 1 Consortium study (ADVL1314).","society":"ASCO","meeting":"ASCO Annual Meeting","year":2016,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.2567","source_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.2567","status":"verified"},{"title":"Abstract 1450: Autopsy derived orthotopic xenograft (ADOX) mouse models for terminal pediatric brain tumors","society":"AACR","meeting":"AACR (meeting unresolved)","year":2015,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2015-1450","source_url":"https://doi.org/10.1158/1538-7445.am2015-1450","status":"verified"}],"source":"congress"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.","year":2024,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article","Clinical Trial, Phase I","Research Support, Non-U.S. Gov't","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38771986/","status":"verified"}],"most_cited":{"total":375,"shown":5,"withheld":370,"rows":[{"title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study","year":2013,"cited_by_count":712,"type":"article","source_url":"https://doi.org/10.1016/s1470-2045(13)70095-0"},{"title":"Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy","year":2005,"cited_by_count":424,"type":"article","source_url":"https://doi.org/10.1200/jco.2005.05.187"},{"title":"Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study","year":2017,"cited_by_count":413,"type":"article","source_url":"https://doi.org/10.1200/jco.2017.73.4830"},{"title":"Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma","year":2001,"cited_by_count":361,"type":"article","source_url":"https://doi.org/10.1200/jco.2001.19.3.697"},{"title":"Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group","year":2005,"cited_by_count":318,"type":"article","source_url":"https://doi.org/10.1200/jco.2005.03.426"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Peter C. Adamson","coauthored_works":103,"profile_url":"https://www.findmykol.com/kol/peter-adamson"},{"name":"Brenda J. Weigel","coauthored_works":82},{"name":"Stacey L. Berg","coauthored_works":79}],"source":"works"},"presence":{"mentions":{"total":4,"shown":3,"rows":[{"url":"https://braintumor.org/news/national-brain-tumor-society-appoints-renowned-pediatric-oncologist-dr-susan-blaney-as-chief-scientific-officer","platform":"other","status":"verified"},{"url":"https://profiles.viictr.org/display/268174","platform":"other","status":"provisional"},{"url":"https://texaschildrens.org/find-a-doctor/susan-m-blaney-md","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"M.D. from Medical College of Ohio (1984)","source_url":"https://www.bcm.edu/people-search/susan-blaney-18483","status":"verified","collected_at":"2026-10-31"},{"value":"B.S. in Chemistry from Xavier University Ohio (1980)","source_url":"https://www.bcm.edu/people-search/susan-blaney-18483","status":"verified","collected_at":"2026-10-31"}]},"roles":{"total":5,"shown":3,"rows":[{"value":"Vice Chair, Children's Oncology Group (NCI-supported clinical trials group)","source_url":"https://texaschildrensnews.org/blaney-appointed-to-american-board-of-pediatrics-oncology-group/","status":"verified","collected_at":"2026-10-31"},{"value":"Chief Scientific Officer, National Brain Tumor Society","source_url":"https://braintumor.org/news/national-brain-tumor-society-appoints-renowned-pediatric-oncologist-dr-susan-blaney-as-chief-scientific-officer","status":"verified","collected_at":"2026-10-31"},{"value":"Member, Hematology-Oncology Self-Assessment Team, American Board of Pediatrics","source_url":"https://texaschildrensnews.org/blaney-appointed-to-american-board-of-pediatrics-oncology-group/","status":"verified","collected_at":"2026-10-31"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"National Cancer Institute Director's Service Award (2018)","source_url":"https://texaschildrensnews.org/blaney-receives-award-from-national-cancer-institute/","status":"verified","collected_at":"2026-10-31"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Texas Children's Hospital","source_url":"https://www.bcm.edu/people-search/susan-blaney-18483","status":"verified","collected_at":"2026-10-31"},{"value":"National Brain Tumor Society (Chief Scientific Officer)","source_url":"https://braintumor.org/news/national-brain-tumor-society-appoints-renowned-pediatric-oncologist-dr-susan-blaney-as-chief-scientific-officer","status":"verified","collected_at":"2026-10-31"}]}},"similar":[{"name":"Christie Ballantyne","slug":"christie-ballantyne","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/christie-ballantyne","json_url":"https://www.findmykol.com/kol/christie-ballantyne/profile.json"},{"name":"Biykem Bozkurt","slug":"biykem-bozkurt","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/biykem-bozkurt","json_url":"https://www.findmykol.com/kol/biykem-bozkurt/profile.json"},{"name":"Malcolm Brenner","slug":"malcolm-brenner","institution":"Baylor College of Medicine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/malcolm-brenner","json_url":"https://www.findmykol.com/kol/malcolm-brenner/profile.json"},{"name":"Garabed Eknoyan","slug":"garabed-eknoyan","institution":"Baylor College of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/garabed-eknoyan","json_url":"https://www.findmykol.com/kol/garabed-eknoyan/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":11,"funding":158,"congress":56,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-31"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-31"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-31"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-31"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-31"}},"methodology_url":"https://www.findmykol.com/about#methodology"}